New study aims to make stem cell transplants safer for kids with leukemia
NCT ID NCT07297914
Summary
This study looks at ways to make stem cell transplants safer and more effective for children and young adults with high-risk or relapsed acute lymphoblastic leukemia (ALL). It involves up to 1,000 participants aged 3 months to 25 years who need a transplant. The goal is to reduce serious side effects and long-term complications while keeping the transplant's ability to fight leukemia.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT -VERSUS-HOST-DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Goethe-Universität
Frankfurt, Germany
-
HUS-Yhtymae (HUS Helsinki University Hospital)
Helsinki, Finland
-
IRCCS Ospedale Pediatrico Bambino Gesù
Roma, RM, 00165, Italy
-
Rigshopsitalet, University Hospital
Copenhagen, Denmark
-
Robert- Debré Academic Hospital
Paris, France
-
St'Anna Children Hospital
Vienna, Austria
-
University Hospital
Oslo, Norway
-
University Hospital Motol
Prague, Czechia
-
University of Medical Sciences
Poznan, Poland
Conditions
Explore the condition pages connected to this study.